Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

CompletedOBSERVATIONAL
Enrollment

4,010

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

April 8, 2024

Conditions
BRCA1/2 MutationBreast-conserving Surgery
Interventions
PROCEDURE

Breast-conserving surgery

Breast-conserving surgery, also known as breast-conserving therapy or lumpectomy, is a surgical procedure used to treat breast cancer while preserving as much of the breast tissue as possible. During this procedure, the surgeon removes the cancerous tumor along with a surrounding margin of normal tissue. The goal is to remove the cancerous cells while maintaining the appearance and function of the breast as much as possible.

Trial Locations (1)

Unknown

Hanyang university hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Korean Surgical Society

UNKNOWN

collaborator

Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group

UNKNOWN

lead

Hanyang University Seoul Hospital

OTHER